ARCHIVES

In Brief: Stetten’s Deputy, Von Euler, Takes Over At NIGMS; Sherman’s Replacement Probably Will Be In-House

This article is from The Cancer Letter archive.

Vol. 01 No. 06 | March 15, 1974

Download PDF Visit The Full Archive

Related Articles

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

In Congress: Clinton Backs Genetic Privacy Bills, But Plans Changes Proposals

July 18, 1997

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

NCI Offers Bibliography On Risk Communication.

March 23, 2001

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011